An interventional study of Laborie LMT Pharyngeal System (3.7 mm catheter) and Medtronic ManoScan ESO HRM System (4.2 mm catheter) in Dysphagia, sponsored by University of Wisconsin, Madison. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Deglutition Disorders by University of Wisconsin, Madison — 1 open to participants now, 1 under way, none of them phase 3. Deglutition Disorders · University of Wisconsin, Madison.
Among the 12 studies in Deglutition Disorders by University of Wisconsin, Madison, this one is the only one that started in 2026, is one of 5 with no phase, and was the 12th registered.
873 studies on the registry are indexed under Deglutition Disorders; 236 are open to participants now.
Browse Deglutition Disorders studies →1 of the 12 studies in Deglutition Disorders by University of Wisconsin, Madison is open now, in 1 country.
By country, each count listing its studies:
Of the 138 Deglutition Disorders studies recruiting now, 75 (54%) set no upper age limit and 27 (20%) stop at 75 or younger; 16 take children under 18; 20 take healthy volunteers.
This study: 18 Years to 99 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 25 is below the median of 60 across 579 interventional studies indexed under Deglutition Disorders.
Median enrollment 32 across the 6 interventional studies, 62 across the 6 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Wisconsin, Madison is the lead sponsor of 1,189 studies on the registry; 182 are open to participants now.
Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.
1 of the studies in Deglutition Disorders by University of Wisconsin, Madison that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07475091University of Wisconsin, MadisonStandardizing Swallow Pressure Measurements | 2027-09 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Deglutition Disorders by University of Wisconsin, Madison, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to directly compare and contrast swallowing pressure and impedance measurements obtained from two high-resolution manometry (HRM) systems: the Laborie LMT Pharyngeal System and the Medtronic ManoScan ESO HRM System in healthy adult volunteers. The primary objective is to determine how differences in catheter diameter, sensor configuration, and acquisition platforms influence measurement outcomes. Twenty-five healthy adults will participate in a single, approximately 2-hour visit; the study will be open for one year for data collection and two years for data analysis.
The primary objective is to obtain, compare, and contrast directly the measured swallow between the Laborie Pharyngeal HRM impedance system with the 3.7 mm catheter and the Medtronic HRM impedance system with the 4.2 mm catheter in the same setting with normal healthy volunteers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This study will include a data collection session that involves swallowing tasks during HRM.
Device: Laborie LMT Pharyngeal System (3.7 mm catheter) · Device: Medtronic ManoScan ESO HRM System (4.2 mm catheter)
This study will include a data collection session that involves swallowing tasks during HRM.
Device: Laborie LMT Pharyngeal System (3.7 mm catheter) · Device: Medtronic ManoScan ESO HRM System (4.2 mm catheter)
The Solar GI HRM system is intended to record, store, view, and analyze pressure, impedance, EMG, swallow and respiration, and various auxiliary input device data online anywhere in the gastrointestinal tract (pharynx; esophagus; stomach; duodenum; sphincter of Oddi; small bowel; colon and anorectal area, including rectum and pelvic floor) to assist in the diagnosis and evaluation of gastrointestinal and swallowing disorders. Used with 3.7 mm catheter.
Also known as: Laborie HRM impedance system, Laborie Solar™ GI HRM Solid-State, Trolley System (G3-9), Laborie Solid State HRIM Catheter (K83659-E-1820-D)
The ManoScan™ ESO high resolution manometry system enables full evaluation of the motor functions of the esophagus. The system provides useful information to support diagnosis of conditions like dysphagia, achalasia, and hiatal hernia. A 36-channel circumferential solid-state catheter with 4.2 mm diameter, 1.0 cm spacing between adjacent sensors.
Also known as: Medtronic HRM impedance system, Medtronic ManoScan™ ESO high resolution manometry system, Medtronic ManoScan360 HRM catheter
Base of tongue pressure
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Hypopharyngeal peak pressure
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Pharyngeal Contractile Integral (PhCI)
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Pressure rise time
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Contractile front velocity
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Upper Esophageal Sphincter (UES) resting pressure
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
UES peak contraction pressure
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
UES relaxation nadir pressure
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
UES relaxation duration
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Nadir impedance
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Bolus presence time
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Flow interval
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Pressure-flow index component
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Timing relationships (onset-to-peak intervals)
Measured with both Laborie HRM impedance system and Medtronic HRM impedance system for comparison.
Time frame: data collected during 1 study visit (up to 2 hours)
Construction of Spatial pressure distribution maps
Multi-level modeling for repeated measures across bolus types, volumes, and repetitions. Sensor-level and region-level analyses (BOT, hypopharynx, UES). Agreement thresholds and bias definitions added to facilitate interpretability and ensure clarity for cross-platform comparison. Map layers will be summarized as a proxy for this measure.
Time frame: data collected during 1 study visit (up to 2 hours)
Plan to share: Yes
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Sep 2027, 10 months later.
Of 290 non-industry interventional studies with no phase under Deglutition Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 10 months is below that.
Counting every sponsor, half of 299 studies reached it within 21 months; a quarter within 10 and three quarters within 38.
Start moved twice since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2026, last on Nov 2, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Wisconsin, Madison →